Adenosine Deaminase Deficiency
Also known as: ADA Deficiency / Adenosine deaminase deficiency, unspecified / Adenosine deaminase [ADA] deficiency / Adenosine deaminase deficiency (disorder) / Combined immunodeficiency, unspecified / Combined immunodeficiency / Combined immunodeficiency syndrome / Combined immunity deficiency / Combined immunodeficiencies / Combined immunodeficiency disease (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00061 | Pegademase | A modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00061 | Pegademase | Adenosine | target |
DB00061 | Pegademase | Growth factor receptor-bound protein 2 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00091 | Cyclosporine | 1 | Completed | 1 |
DB00688 | Mycophenolate mofetil | 1 | Completed | 1 |
DB01008 | Busulfan | 1 / 2 | Completed | 1 |
DB14712 | Elapegademase | 3 | Completed | 1 |
DB00061 | Pegademase | 3 | Completed | 1 |
DB00640 | Adenosine | Not Available | Enrolling by Invitation | 1 |
DB14712 | Elapegademase | Not Available | Completed | 1 |